| Nov 1 |
Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data
|
| Oct 31 |
Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million
|
| Oct 30 |
Tiziana Life Sciences Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination Study
|
| Oct 28 |
Discover October 2024's Promising US Penny Stocks
|
| Oct 26 |
Tiziana Life Sciences Plans Share Sale with Jefferies
|
| Oct 19 |
Tiziana Life Sciences Advances with Promising Drug Trials
|
| Oct 10 |
Elon Musk May Unveil Tesla's Robotaxi, But Consumers Respond With 'Ehhh,' New Study Reveals Skepticism, Need For Trust-Building
|
| Sep 19 |
Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s Disease
|
| Aug 19 |
Tiziana Life Sciences appoints Elrifi as CEO
|
| Aug 19 |
Tiziana Life Sciences Appoints New Chief Executive Officer
|
